ReviewEnvironmental science & technology2026
Planetary Boundary for Novel Entities: Time for a Reboot.
Review in Environmental science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Novel entities are diverse and complex; hence, defining their Planetary Boundary through control variables, indicators, and acceptable limits is challenging. Here, we highlight shortcomings of the current quantitative boundary, which applies a purely precautionary interpretation of safety that defines the safe operating space as zero novel entities that are not fully characterized. In practice, the zero limit is unattainable and undesirable for human societies that rely on services provided by novel entities. Furthermore, it is not operational within the framework of other boundaries, which have risk-based thresholds. We therefore propose a reboot of the Planetary Boundary for Novel Entities and recommend governance and monitoring strategies based on: (a) clarification of the "safe operating space" for novel entities, distinguishing pure precaution ("safe from the unknown") from operational precaution that tolerates a workable, non-zero level of uncertainty; (b) complementary, multilayer control variables spanning pressures, states, and impacts; (c) extensions to existing monitoring systems to provide quantitative indicators of distribution, accumulation, exposure, and impacts for subsets of novel entities to communicate the status and trends of stress from novel entities on the Earth system; and (d) recognition of regulatory and policy-related success stories that illustrate comprehensive, protective, and operational governance of novel entities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.